Skip to content

Clinical trials

Terminated Carcinoma, Renal Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Terminated Country / region: France Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20102
20123
20131
20173
20193
20201
20212
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Eli Lilly and Company2
Gustave Roussy, Cancer Campus, Grand Paris2
Hoffmann-La Roche2
AVEO Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
Associació per a la Recerca Oncologica, Spain1
Bayer1
Centre Francois Baclesse1
Centre Hospitalier Universitaire de Saint Etienne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell23
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis3
Neoplasms3
Triple Negative Breast Neoplasms3
Anus Neoplasms2
Biliary Tract Neoplasms2
Carcinoma, Hepatocellular2
Head and Neck Neoplasms2
Kidney Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.